IEX

IDEX Corporation 10-Q Summary: Quarter Ended September 30, 2007

Business Context and Reporting Period

This is a Quarterly Report (Form 10-Q) for IDEX Corporation, a Delaware corporation specializing in fluid and metering technologies, health and science technologies, dispensing equipment, and fire/safety products. The report covers the three and nine months ended September 30, 2007. The company operates as a large accelerated filer with 81,492,424 shares of common stock outstanding as of October 26, 2007.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 16% in Q3 and 19% for the nine-month period. Growth was driven by acquisitions (9% in Q3, 10% YTD), organic growth (5% in Q3, 6% YTD), and favorable foreign currency translation.
• Profitability: Income from continuing operations rose 16% in Q3 and 20% YTD. However, total Net Income decreased 18% in Q3 compared to 2006 due to a significant one-time gain from discontinued operations in the prior year ($12.7 million) versus a small loss in the current year ($0.4 million).
• Segment Performance:
  • Fluid & Metering Technologies: Sales up 35% (Q3) driven by acquisitions (Faure Herman, Quadro) and strong infrastructure demand.
  • Dispensing Equipment: Sales flat; operating margins compressed to 14.7% from 22.2% due to reduced volume, operational issues, and unfavorable mix.
  • Fire & Safety: Sales up 8%; margins declined slightly due to weak North American fire suppression demand.
• Acquisitions: The company acquired Faure Herman (Feb 2007) and Quadro Engineering (June 2007), contributing significantly to the Fluid & Metering segment.
• Discontinued Operations: The sale of the Halox business was completed in Q3 2007, resulting in a $0.1 million after-tax loss. The prior year included a $13.0 million gain from the sale of Lubriquip.

Guidance, Outlook, and Risks

• Q4 2007 Outlook: Management projects fourth-quarter sales growth of 12% to 15%. Diluted EPS is expected to be between $0.46 and $0.49 per share. This range includes a projected unfavorable impact of $0.01 to $0.02 from severance and field service expenses.
• Segment Outlook: Organic growth is projected at 6-8% for Fluid & Metering, 3-5% for Health & Science, 4-6% for Dispensing Equipment, and 4-5% for Fire & Safety.
• Liquidity: The company maintains a $600 million revolving credit facility with $455.3 million available. $150 million in Senior Notes are due in February 2008; management is evaluating options for repayment or refinancing.
• Risks: Key risks include economic conditions, foreign currency fluctuations, integration of acquisitions, and asbestos-related litigation (though currently covered by insurance and not expected to be material).
• Subsequent Event: In October 2007, IDEX acquired Isolation Technologies for approximately $30 million.

Investor Verification Checklist

• Debt Maturity: Verify the company's plan for the $150 million Senior Notes due February 15, 2008, and the impact on liquidity.
• Dispensing Equipment Margins: Monitor the recovery of operating margins in the Dispensing Equipment segment, which dropped significantly due to operational inefficiencies and volume issues.
• Acquisition Integration: Assess the performance contribution of Faure Herman and Quadro Engineering to ensure they meet projected growth targets.
• Discontinued Operations: Confirm that the volatility in Net Income caused by discontinued operations (gains/losses on sales) does not obscure the underlying performance of continuing operations.
• Asbestos Litigation: Review updates on insurance coverage for asbestos-related claims to ensure no unexpected liabilities arise.